{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:47:04Z","timestamp":1791226024119,"version":"4.1.0"},"reference-count":28,"publisher":"Portland Press Ltd.","issue":"5","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":2626,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,9,1]]},"abstract":"<jats:p>BNP (B-type natriuretic peptide) has been reported to be elevated in preclinical states of vascular damage. To elucidate the relationship between plasma BNP and endothelial function, we have investigated the relationship between BNP and endothelial function in a cohort of subjects comprising healthy subjects as well as at-risk subjects with cardiovascular risk factors. To also clarify the relative contribution of different biological pathways to the individual variation in endothelial function, we have examined the relationship between a panel of multiple biomarkers and endothelial function. A total of 70 subjects were studied (mean age, 58.1\u00b14.6\u00a0years; 27% had a history of hypertension and 18% had a history of hypercholesterolaemia). Endothelium-dependent vasodilatation was evaluated by the invasive ACH (acetylcholine)-induced forearm vasodilatation technique. A panel of biomarkers of biological pathways was measured: BNP, haemostatic factors PAI-1 (plasminogen-activator inhibitor 1) and tPA (tissue plasminogen activator), inflammatory markers, including cytokines [hs-CRP (high sensitive C-reactive protein), IL (interleukin)-6, IL-8, IL-18, TNF\u03b1 (tumour necrosis factor \u03b1) and MPO (myeloperoxidase] and soluble adhesion molecules [E-selectin and sCD40 (soluble CD40)]. The median BNP level in the study population was 26.9 pg\/ml. Multivariate regression analyses show that age, the total cholesterol\/HDL (high-density lipoprotein) ratio, glucose and BNP were independent predictors of endothelial function, and BNP remained an independent predictor (P=0.009) in a binary logistic regression analysis using FBF (forearm blood flow) as a dichotomous variable based on the median value. None of the other plasma biomarkers was independently related to ACH-mediated vasodilatation. In a strategy using several biomarkers to relate to endothelial function, plasma BNP was found to be an independent predictor of endothelial function as assessed by endothelium-dependent vasodilatation in response to ACH.<\/jats:p>","DOI":"10.1042\/cs20110168","type":"journal-article","created":{"date-parts":[[2012,3,26]],"date-time":"2012-03-26T08:27:56Z","timestamp":1332750476000},"page":"307-312","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["B-type natriuretic peptide is an independent predictor of endothelial function in man"],"prefix":"10.1042","volume":"123","author":[{"given":"Maheshwar","family":"Pauriah","sequence":"first","affiliation":[{"name":"Centre for Cardiovascular and Lung Biology, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisel","family":"Khan","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular and Lung Biology, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiong\u00a0K.","family":"Lim","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular and Lung Biology, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas\u00a0H.","family":"Elder","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular and Lung Biology, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Godfrey","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular and Lung Biology, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular and Lung Biology, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill\u00a0J.\u00a0F.","family":"Belch","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular and Lung Biology, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuala\u00a0A.","family":"Booth","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular and Lung Biology, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan\u00a0D.","family":"Struthers","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular and Lung Biology, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chim\u00a0C.","family":"Lang","sequence":"additional","affiliation":[{"name":"Centre for Cardiovascular and Lung Biology, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2012,5,16]]},"reference":[{"key":"2021113010234641400_B1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ajh.2008.174","article-title":"Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases","volume":"21","author":"Rubattu","year":"2008","journal-title":"Am. J. Hypertens."},{"key":"2021113010234641400_B2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.tem.2006.06.006","article-title":"Membrane guanylyl cyclase receptors: an update","volume":"17","author":"Garbers","year":"2006","journal-title":"Trends Endocrinol. Metab."},{"key":"2021113010234641400_B3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00004872-200203000-00025","article-title":"Nitric oxide and potassium channels are involved in brain natriuretic peptide induced vasodilatation in man","volume":"20","author":"van der Zander","year":"2002","journal-title":"J. Hypertens."},{"key":"2021113010234641400_B4","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1161\/01.CIR.0000143073.60937.50","article-title":"Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide","volume":"110","author":"Chong","year":"2004","journal-title":"Circulation"},{"key":"2021113010234641400_B5","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1161\/CIRCULATIONAHA.105.580233","article-title":"Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function","volume":"113","author":"Kathiresan","year":"2006","journal-title":"Circulation"},{"key":"2021113010234641400_B6","first-page":"125","article-title":"Elevated levels of brain natriuretic peptide as a predictor of impaired coronary endothelial function in patients with left ventricular remodeling","volume":"48","author":"Ninomiya","year":"2006","journal-title":"J. Cardiol."},{"key":"2021113010234641400_B7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.0306-5251.2001.01495.x","article-title":"Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications","volume":"52","author":"Wilkinson","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2021113010234641400_B8","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.4065\/80.8.1029","article-title":"B-type natriuretic peptide as a biomarker beyond heart failure: speculations and opportunities","volume":"80","author":"McKie","year":"2005","journal-title":"Mayo Clin. Proc."},{"key":"2021113010234641400_B9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/3-540-36028-X_9","article-title":"Vascular endothelium and atherosclerosis","author":"Libby","year":"2006","journal-title":"Handbook Exp. Pharmacol."},{"key":"2021113010234641400_B10","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Follow-up report on the diagnosis of diabetes mellitus","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care"},{"key":"2021113010234641400_B11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2141.1988.tb02490.x","article-title":"Plasminogen activator inhibitor (PAI-1) in plasma and platelets","volume":"70","author":"Booth","year":"1988","journal-title":"Br. J. Haematol."},{"key":"2021113010234641400_B12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0268-9499(87)90044-0","article-title":"monoclonal antibody enzyme-linked immunosorbent assay (ELISA) directed towards a fibrin binding region of tissue-type plasminogen activator","volume":"1","author":"MacGregor","year":"1987","journal-title":"Fibrinolysis"},{"key":"2021113010234641400_B13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJM199507203330304","article-title":"Attenuation of isoproterenol-mediated vasodilatation in blacks","volume":"333","author":"Lang","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"2021113010234641400_B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.1953.sp004926","article-title":"The measurement of volume changes in human limbs","volume":"121","author":"Whitney","year":"1953","journal-title":"J. Physiol."},{"key":"2021113010234641400_B15","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.amjcard.2005.06.073","article-title":"Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of N-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study)","volume":"96","author":"Abdullah","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"2021113010234641400_B16","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0140-6736(92)93147-F","article-title":"Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis","volume":"340","author":"Celermajer","year":"1992","journal-title":"Lancet"},{"key":"2021113010234641400_B17","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.amjcard.2008.12.014","article-title":"B-type natriuretic peptides and their relation to cardiovascular structure and function in a population- based sample of subjects aged 70 years","volume":"103","author":"Eggers","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"2021113010234641400_B18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jacc.2004.02.054","article-title":"Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease","volume":"44","author":"Fichtlscherer","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113010234641400_B19","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.CIR.102.9.1000","article-title":"Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease","volume":"102","author":"Fichtlscherer","year":"2000","journal-title":"Circulation"},{"key":"2021113010234641400_B20","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1161\/01.CIR.0000148821.97162.5E","article-title":"Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study","volume":"110","author":"Vita","year":"2004","journal-title":"Circulation"},{"key":"2021113010234641400_B21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0895-7061(00)01276-0","article-title":"Soluble E-selectin in essential hypertension: a correlate of vascular structural changes","volume":"14","author":"De Caterina","year":"2001","journal-title":"Am. J. Hypertens."},{"key":"2021113010234641400_B22","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.ehj.2004.06.039","article-title":"Cross-sectional evaluation of brachial artery flow-mediated vasodilation and C-reactive protein in healthy individuals","volume":"25","author":"Verma","year":"2004","journal-title":"Eur. Heart J."},{"key":"2021113010234641400_B23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.atherosclerosis.2007.09.038","article-title":"C-reactive protein and e-selectin levels are related to vasodilation in resistance, but not conductance arteries in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study","volume":"199","author":"Lind","year":"2008","journal-title":"Atherosclerosis"},{"key":"2021113010234641400_B24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11892-007-0043-1","article-title":"Arterial compliance and endothelial function","volume":"7","author":"Correia","year":"2007","journal-title":"Curr. Diab. Rep."},{"key":"2021113010234641400_B25","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.amjhyper.2005.06.016","article-title":"B-type natriuretic peptide is associated with both augmentation index and left ventricular mass in diabetic patients without heart failure","volume":"18","author":"Dawson","year":"2005","journal-title":"Am. J. Hypertens."},{"key":"2021113010234641400_B26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/HYPERTENSIONAHA.107.090068","article-title":"Central blood pressure measurements and antihypertensive therapy: a consensus document","volume":"50","author":"Agabiti-Rosei","year":"2007","journal-title":"Hypertension"},{"key":"2021113010234641400_B27","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1096\/fj.02-0796fje","article-title":"Increased cardiac BNP expression associated with myocardial ischemia","volume":"17","author":"Goetze","year":"2003","journal-title":"FASEB J."},{"key":"2021113010234641400_B28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/qjmed\/hci111","article-title":"B-type natriuretic peptide: a simple new test to identify coronary artery disease?","volume":"98","author":"Struthers","year":"2005","journal-title":"Q. J. Med."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/123\/5\/307\/443114\/cs1230307.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/123\/5\/307\/443114\/cs1230307.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T10:52:38Z","timestamp":1638269558000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/123\/5\/307\/69036\/B-type-natriuretic-peptide-is-an-independent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,16]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20110168","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,16]]}}}